Junctional Epidermolysis Bullosa
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
Breeding advice appliesUse the screening guidance and veterinary or genetics advice before breeding an affected or at-risk animal.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Junctional epidermolysis bullosa, or JEB, is a group of lethal recessive skin-fragility disorders in which the epidermis fails to anchor normally to the underlying basement membrane. Distinct variants affect Belgian and related draft horses and American Saddlebreds; defects involve different laminin components, so the correct breed-specific DNA test matters.
Affected foals are born with blisters, raw areas or skin that sloughs after minimal friction. Lesions rapidly develop over pressure points, limbs, mouth and sites contacted during nursing. Hoof capsules may separate or be shed, and oral ulceration makes suckling painful. A foal can be born with few visible lesions and deteriorate as standing and maternal grooming apply normal mechanical stress. Infection, fluid loss, pain and inability to bear weight follow.
JEB differs from FFS1 in its molecular attachment defect and from HERDA in breed, layer of separation and neonatal onset. Birth trauma, burns, infection and pemphigus can also cause erosions but do not usually produce the same progressive friction-induced pattern. The syndrome is not contagious.
Inheritance is autosomal recessive. Carriers are outwardly normal; two carriers face a 25% affected risk in every mating. There is no treatment that restores basement-membrane adhesion throughout the body. Affected foals die or require early humane euthanasia, making prognosis hopeless. Correct variant testing is crucial: a negative result for Belgian JEB does not clear a Saddlebred for its separate form. Breed-specific screening before mating provides reliable prevention without removing all healthy carriers from breeding.
Separation occurs at the basement-membrane junction, so intact-looking skin can lift away after rubbing and reveal a raw surface. Hoof loss is especially disabling because the foal cannot distribute weight without further tissue injury. Distinct laminin-chain mutations in draft and Saddlebred populations make a generic “JEB negative” statement potentially misleading.
Screening & Early Detection
The veterinarian maps erosions, blisters, oral lesions and hoof separation and notes how rapidly new damage appears after friction. The foal is examined on padded bedding with minimal restraint. Cytology and culture assess secondary infection, while blood work evaluates dehydration, protein loss and systemic involvement.
DNA testing selects the validated variant for the breed—commonly LAMC2-associated JEB in Belgian draft lines and a separate laminin-related form in Saddlebreds. Results identify clear, carrier or affected status. Skin biopsy taken with extreme care can show separation at the junction and immunohistochemistry or electron microscopy may define the missing attachment protein.
Differentials include FFS1, HERDA, trauma, bacterial skin disease and autoimmune blistering. Parentage and permanent identification accompany genetic samples. Breeding animals from at-risk lines are tested while healthy, and abortions or foals dying with hoof loss are sampled. One breed's negative panel is not treated as a universal JEB clearance.
The mouth and coronary bands are inspected even when the first visible lesion is elsewhere.
Treatment & Management
There is no definitive therapy. While confirmation is pending, the foal is protected on deep soft bedding, handled minimally and given analgesia. Wounds receive gentle cleansing and non-adherent coverage; fluids, plasma, nutrition and antimicrobials may address immediate losses or infection. These measures cannot prevent new surfaces from separating under normal movement, nursing and weight bearing.
Once JEB is established, prompt humane euthanasia prevents escalating pain, hoof sloughing, sepsis and starvation. Repeated grafting, suturing or prolonged bandaging is futile because untreated skin elsewhere has the same molecular defect. The mare receives appropriate postpartum care, and necropsy samples are retained when genotype remains uncertain.
Prevention requires the correct breed-specific DNA test. Carrier-to-carrier matings are avoided; carrier-to-clear matings produce no affected foals for that variant, though carrier offspring need testing before breeding. Carriers themselves do not need treatment. Results are attached to registered identity and disclosed for live cover, semen and embryo transfer. If a clinically compatible case tests negative on one panel, further diagnostic work continues rather than declaring the syndrome impossible, because genetically distinct forms exist.
Pain control is maintained during confirmation rather than withheld because the prognosis is grave.
